Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $292.35 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $124.09 | 1 | $0 (2019) |
| Boston Scientific Corporation | $105.74 | 1 | $0 (2023) |
| BioMarin Pharmaceutical Inc. | $42.54 | 2 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $19.98 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.98 | 1 | Otsuka America Pharmaceutical, Inc. ($19.98) |
| 2023 | $148.28 | 3 | Boston Scientific Corporation ($105.74) |
| 2019 | $124.09 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($124.09) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/03/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: PSYCHIATRY | ||||||
| 11/15/2023 | Boston Scientific Corporation | Ranger (Device) | Food and Beverage | In-kind items and services | $105.74 | General |
| Category: Ranger_PI | ||||||
| 06/09/2023 | BioMarin Pharmaceutical Inc. | Palynziq (Drug) | Food and Beverage | In-kind items and services | $26.29 | General |
| Category: PKU | ||||||
| 02/17/2023 | BioMarin Pharmaceutical Inc. | Kuvan (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: PKU | ||||||
| 08/13/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $124.09 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 197 | 281 | $90,796 | $25,845 |
| 2022 | 6 | 276 | 391 | $118,453 | $34,479 |
| 2021 | 8 | 263 | 364 | $114,582 | $32,315 |
| 2020 | 3 | 81 | 105 | $22,180 | $8,146 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 156 | $62,400 | $14,531 | 23.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 51 | 51 | $11,934 | $7,175 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 38 | 47 | $14,476 | $2,783 | 19.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 12 | 12 | $1,116 | $863.16 | 77.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 15 | $870.00 | $493.05 | 56.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 101 | 200 | $82,704 | $19,182 | 23.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 54 | 54 | $12,636 | $7,625 | 60.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 40 | 56 | $17,248 | $3,993 | 23.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 29 | 29 | $2,697 | $1,988 | 73.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 33 | 33 | $1,914 | $1,072 | 56.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $1,254 | $618.96 | 49.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 89 | 163 | $69,743 | $16,325 | 23.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 60 | 86 | $24,057 | $6,048 | 25.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 21 | 21 | $7,623 | $3,837 | 50.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 20 | 20 | $4,680 | $2,894 | 61.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 21 | 21 | $1,953 | $1,370 | 70.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $4,152 | $1,108 | 26.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 25 | 25 | $1,450 | $470.75 | 32.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 13 | 14 | $924.00 | $262.66 | 28.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 40 | 52 | $14,612 | $5,119 | 35.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 30 | 42 | $6,930 | $2,825 | 40.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 11 | 11 | $638.00 | $201.85 | 31.6% |
About Dr. Thomas Wall, MD
Dr. Thomas Wall, MD is a Family Medicine healthcare provider based in Blackwood, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2017. The National Provider Identifier (NPI) number assigned to this provider is 1952822595.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Wall, MD has received a total of $292.35 in payments from pharmaceutical and medical device companies, with $19.98 received in 2024. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($292.35).
As a Medicare-enrolled provider, Wall has provided services to 817 Medicare beneficiaries, totaling 1,141 services with total Medicare billing of $100,785. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Blackwood, NJ
- Active Since 07/05/2017
- Last Updated 08/19/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1952822595
Products in Payments
- Ranger (Device) $105.74
- Palynziq (Drug) $26.29
- REXULTI (Drug) $19.98
- Kuvan (Drug) $16.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.